Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets

Photodynamic therapy (PDT) is a kind of photochemo‐therapeutic treatment that exerts its effect mainly through the induction of cell death. Distinct types of cell death may be elicited by different PDT regimes. In this study, the mechanisms involved in the death of human epidermoid carcinoma A431 cells triggered by PDT with Photofrin® (a clinically approved photosensitizer) were characterized. Photofrin distributes dynamically in A431 cells; the plasma membranes and Golgi complex are the main target sites of Photofrin after a brief (3 h) and prolonged (24 h) incubation, respectively. Cells with differentially localized Photofrin displayed distinct death phenotypes in response to PDT. The effects of PDT on cells with plasma membrane‐localized Photofrin were further studied in details. Cells stopped proliferating post PDT at Photofrin dose >7 μg/ml, and at higher dose (28 μg/ml) plasma membrane disruption and cell swelling were observed immediately after PDT. Dramatic alterations of several important signaling events were detected in A431 cells post Photofrin®‐PDT, including (i) immediate formation of reactive oxygen species (ROS), (ii) rapid activation of c‐Jun N‐terminal kinase, (iii) delayed activation of caspase‐3 and cleavage of polyADP‐ribose polymerase and p21‐activated kinase 2, and (iv) loss of mitochondrial membrane potential. Intriguingly, the characteristics of typical apoptosis such as phosphatidylserine externalization and DNA fragmentation were not detected in the cell death process caused by this PDT regime. In conclusion, our results show that when plasma membranes are the main targets, Photofrin‐PDT can lead to instant ROS formation and subsequent activation of downstream signaling events similar to those elicited by many apoptotic stimuli, but the damage of plasma membranes renders the death phenotype more necrosis like. © 2003 Wiley‐Liss, Inc.

[1]  N. Oleinick,et al.  Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment. , 1998, Cancer research.

[2]  Hedy E. Larkin,et al.  Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. , 1993, Cancer research.

[3]  T. Tsuruo,et al.  Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. , 1997, Blood.

[4]  M L Agarwal,et al.  Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.

[5]  Sharon Thomsen,et al.  PHOTODYNAMIC THERAPY WITH PHOTOFRIN II INDUCES PROGRAMMED CELL DEATH IN CARCINOMA CELL LINES , 1994, Photochemistry and photobiology.

[6]  G. Buettner,et al.  Membrane lipid free radicals produced from L1210 murine leukemia cells by photofrin photosensitization: an electron paramagnetic resonance spin trapping study. , 1993, Cancer research.

[7]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[8]  D. Kessel,et al.  The Role of Subcellular Localization in Initiation of Apoptosis by Photodynamic Therapy , 1997, Photochemistry and photobiology.

[9]  A. Girotti,et al.  Role of lipid peroxidation in hematoporphyrin derivative-sensitized photokilling of tumor cells: protective effects of glutathione peroxidase. , 1989, Cancer research.

[10]  N. Oleinick,et al.  Promotion of photodynamic therapy-induced apoptosis by stress kinases , 1999, Cell Death and Differentiation.

[11]  P. Vandenabeele,et al.  Apoptotic and necrotic cell death induced by death domain receptors , 2001, Cellular and Molecular Life Sciences CMLS.

[12]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[13]  N. Brown,et al.  Differential cell death response to photodynamic therapy is dependent on dose and cell type , 2001, British Journal of Cancer.

[14]  N. Oleinick,et al.  Photodynamic Therapy-induced Apoptosis in Epidermoid Carcinoma Cells , 2001, The Journal of Biological Chemistry.

[15]  G. Kroemer,et al.  The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death , 1997, Oncogene.

[16]  T. Dougherty,et al.  A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. , 1996, Journal of clinical laser medicine & surgery.

[17]  L. Formigli,et al.  Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis , 2000, Journal of cellular physiology.

[18]  M L Walsh,et al.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy , 1981, The Journal of cell biology.

[19]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[20]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[21]  C. Salet.  Hematoporphyrin and hematoporphyrin-derivative photosensitization of mitochondria. , 1986, Biochimie.

[22]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[23]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[25]  G. Miotto,et al.  Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. , 2001, Cancer research.

[26]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[27]  P. Vandenabeele,et al.  The Activation of the c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase Signaling Pathways Protects HeLa Cells from Apoptosis Following Photodynamic Therapy with Hypericin* , 1999, The Journal of Biological Chemistry.

[28]  J. Farber,et al.  The Cytotoxicity of Tumor Necrosis Factor Depends on Induction of the Mitochondrial Permeability Transition* , 1996, The Journal of Biological Chemistry.

[29]  S. Yang,et al.  Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2. , 2000, The Biochemical journal.

[30]  N. Oleinick,et al.  APOPTOSIS DURING PHOTODYNAMIC THERAPY‐INDUCED ABLATION OF RIF‐1 TUMORS IN C3H MICE: ELECTRON MICROSCOPIC, HISTOPATHOLOGIC AND BIOCHEMICAL EVIDENCE , 1993, Photochemistry and photobiology.

[31]  Jau-Song Yu,et al.  Reversible tyrosine phosphorylation/dephosphorylation of proline‐directed protein kinase FA/glycogen synthase kinase‐3α in A431 cells , 1997, Journal of cellular physiology.

[32]  F. Schliess,et al.  Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. , 1998, Cancer research.

[33]  S. Gibson,et al.  Photosensitizing effects of Photofrin II on the site-selected mitochondrial enzymes adenylate kinase and monoamine oxidase. , 1987, Cancer research.

[34]  S. Pelech,et al.  Stimulation of Stress-activated Protein Kinase and p38 HOG1 Kinase in Murine Keratinocytes following Photodynamic Therapy with Benzoporphyrin Derivative* , 1996, The Journal of Biological Chemistry.

[35]  D. Kessel,et al.  Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma Model , 1997, Photochemistry and photobiology.

[36]  G. Kroemer.  [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.

[37]  C. McMaster,et al.  Preferential externalization of newly synthesized phosphatidylserine in apoptotic U937 cells is dependent on caspase-mediated pathways. , 2000, Biochimica et biophysica acta.

[38]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[39]  C. Reutelingsperger,et al.  Flow cytometry of apoptotic cell death. , 2000, Journal of immunological methods.

[40]  S. Hahn,et al.  Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. , 1999, Cancer research.

[41]  J. Ferguson,et al.  Drug and chemical photosensitivity. , 1990, Seminars in dermatology.

[42]  Y Lajat,et al.  Cellular distribution and phototoxicity of Benzoporphyrin derivative and Photofrin , 1999, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[43]  M W Berns,et al.  In vitro photosensitization II. An electron microscopy study of cellular destruction with mono‐L‐aspartyl chlorin e6 and photofrin II , 1989, Lasers in surgery and medicine.

[44]  Q. Peng,et al.  Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.

[45]  M. Dellinger.  Apoptosis or Necrosis Following Photofrin® Photosensitization: Influence of the Incubation Protocol , 1996, Photochemistry and photobiology.

[46]  Z. Wang,et al.  An assay for DNA fragmentation in apoptosis without phenol/chloroform extraction and ethanol precipitation. , 1997, Analytical biochemistry.

[47]  K. Kohn,et al.  Induction of a common pathway of apoptosis by staurosporine. , 1994, Experimental cell research.

[48]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[49]  S. Gibson,et al.  Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas. , 1988, Cancer research.

[50]  R. Haugland,et al.  A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor , 1991, The Journal of cell biology.

[51]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.